ISSN: 1871-5249

Journal Home

Journal Guideline

Central Nervous System Agents in Medicinal Chemistry Q4 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Central Nervous System Agents in Medicinal Chemistry is a journal indexed in SJR in Molecular Medicine and Neuroscience (miscellaneous) with an H index of 39. It has an SJR impact factor of 0,283 and it has a best quartile of Q4. It has an SJR impact factor of 0,283.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Molecular Medicine (Q4) Neuropsychology and Physiological Psychology (Q4) Neuroscience (miscellaneous) (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Central Nervous System Agents in Medicinal Chemistry

0,283

SJR Impact factor

39

H Index

22

Total Docs (Last Year)

60

Total Docs (3 years)

1112

Total Refs

86

Total Cites (3 years)

57

Citable Docs (3 years)

1.45

Cites/Doc (2 years)

50.55

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pteridines Q4
Current Cancer Therapy Reviews Q4
Cellular Therapy and Transplantation Q4
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry Q4
Current Enzyme Inhibition Q4

Compare this journals

Aims and Scope

Best articles by citations

Challenge and Therapeutic Studies Using Alpha-Methyl-para-Tyrosine (AMPT) in Neuropsychiatric Disorders: A Review

Variability in the Effects of Nicotine on Different Regions of the Brain: Changes in the Concentration of Superoxide Dismutase Isoforms

Editorial (Thematic Issue: Dopamine in the Brain)

Fragment-based Designing for the Generation of Novel Leads Against BACE1

The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System

RETRACTED: Human Suicide, Modern Diagnosis Assistance and Magic Bullet Discovery

Preface:

Preface

Neuropharmacological Profile of Gamma-Decanolactone on hemically-induced Seizure in Mice

Thiazolidin-4-one Derivatives as Central Nervous System Potential Agents

Editorial (Thematic Issue: The Activity of Products from Cnidaria: A Therapeutic Tool in Neurological Diseases - Part 1)

SHOW MORE ARTICLES

Thiazolidin-4-one Derivatives as Central Nervous System Potential Agents

Biomedical Technologies for In Vitro Screening and Controlled Delivery of Neuroactive Compounds

Beneficial Effects of Herbs, Spices and Medicinal Plants on the Metabolic Syndrome, Brain and Cognitive Function

The Glutathione System and its Regulation by Neurohormone Melatonin in the Central Nervous System

Melatonin and Its Therapeutic Potential in Neuroprotection

Brain Molecules and Appetite: The Case of Oleoylethanolamide

Acknowledgements to Reviewers:

Melatonin and Synthetic Melatonergic Agonists: Actions and Metabolism in the Central Nervous System

Biological Activities of QIAPI 1 as a Melanin Precursor and Its Therapeutic Effects in Wistar Rats Exposed to Arsenic Poisoning

Anticonvulsant and Neurological Profile of Benzothiazoles: A Mini-Review